PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 2, 2023Canadian Journal of Cardiology7 citationsOpen Access

Serial Changes in Cardiopulmonary Exercise Testing Parameters in Untreated Patients With Transthyretin Cardiac Amyloidosis

AAAlessia ArgiròMSMaria Vittoria SilveriiCBCostanza Bürgisser

Key Result

Serial cardiopulmonary exercise testing in untreated ATTR-CM patients revealed significant worsening of exercise capacity, including reduced exercise time (-39 s; P<0.01).

Study Design

Type

Observational (n=55)

Multicenter

No

Structured PICO

How do cardiopulmonary exercise testing parameters change over time in untreated patients with transthyretin cardiac amyloidosis?

P
Population
55 untreated patients with transthyretin amyloid cardiomyopathy (ATTR-CM) evaluated at a national referral center
O
Outcome
Changes in cardiopulmonary exercise testing (CPET) parameters over timesurrogate

Serial cardiopulmonary exercise testing can identify early functional decline in untreated ATTR-CM patients before significant echocardiographic changes occur.

Main Result

Effect estimate: -1.29 mL/kg/min (95% CI -1.85 to -0.74)

p-value: p=< 0.01

Abstract

BACKGROUND: Transthyretin amyloid cardiomyopathy (ATTR-CM) is associated with a progressive reduction of functional capacity. The progression of cardiopulmonary exercise testing (CPET) parameters over time is still unknown. METHODS: In this study, 55 patients with ATTR-CM underwent 2 serial cardiologic evaluations and CPETs in a national referral center for cardiac amyloidosis (Careggi University Hospital, Florence). RESULTS: slope were significantly worsened (-1.29 mL/kg/min 95% confidence interval (CI): -1.85 to -0.74; P < 0.01, -4.5% 95% CI: -6.9 to -2.02; P < 0.01, and 8.6 95% CI 6-11; P < 0.01, respectively). Furthermore, exercise time (-39 s, 95% CI: -59 to -19; P < 0.01), exercise tolerance (-0.47 metabolic equivalents, 95% CI: -0.69 to -0.2; P < 0.01), and peak systolic pressure (-10.8 mm Hg, 95% CI: -16.2 to -5.4; P < 0.01) were significantly reduced. The worsening in CPET variables did not correspond with a significant change in echocardiographic parameters. CONCLUSIONS: Cardiorespiratory response to exercise significantly worsened over a short period of time in patients with ATTR-CM. Serial CPET may be useful to identify early disease progression.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Argirò et al. (2023) conducted an observational in Transthyretin amyloid cardiomyopathy (ATTR-CM) (n=55). Serial cardiopulmonary exercise testing (CPET) was evaluated on Change in CPET parameters (-1.29 mL/kg/min, 95% CI -1.85 to -0.74, p=< 0.01). Serial cardiopulmonary exercise testing in untreated ATTR-CM patients revealed significant worsening of exercise capacity, including reduced exercise time (-39 s; P<0.01).

synapsesocial.com/papers/6a14e37f253bd9cd3ce6271chttps://doi.org/10.1016/j.cjca.2023.09.028
Ask AI
Helpful
Bookmark
Share
View Full Paper